Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1M
1 round on record
Latest round
$1M
Convertible Note · Jul 2026 · 3 mo ago
Team
1-10
employees, estimated range
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 16 Raised a round Convertible Note $1M · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Jul 2026 $1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity ImmuNovus, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Tomas HelikarExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Pioneering a New Era of Neural Restoration. As the first company to demonstrate in vivo nerve regeneration via 5-HT2A modulation, we are…
DATABIOMIX leverages actionable insights from our end-to-end validated microbiome metagenomic bioinformatic analysis platforms. Identify…
Infinity BioSeries A $8M · 15 mo ago • Founded 2023 • 51-200 employees
Discover the antibody reactome. Infinity Bio's MIPSA platform reveals past and ongoing immune responses across comprehensive human, viral…
SurgeCareFounded 2021
SurgeCare leverages immune profiling and AI to reveal early immune signatures and drive better decisions in surgery, trauma, infection, and…
Bioinformatics made easy. Take the effort out of the bioinformatics and stay focused on your results. 1928 Diagnostics delivers insights…
Sibylla BiotechSeries A $24.8M · 4 yr ago
Close The story of our foundation PPI-FIT is the result of divergent thinking. It is the outcome of academic excellence at its best, where…

Overview

Making immune complexity predictable and actionable. ImmuNovus combines mechanistic models of the immune system with AI-assisted simulation to explore what may happen, explain why, and identify what to examine next.

People

Tomas Helikar
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Financials

Total raised
$1M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
Round Announced Amount
Convertible Note 2026 $1M Details